Haemonetics (HAE) Tops Q2 EPS by 7c, Beats on Revenues
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $86.22 --0%
EPS Growth %: +15.6%
Financial Fact:
Net revenues: 220.25M
Today's EPS Names:
UXIN, TOWN, NRIM, More
EPS Growth %: +15.6%
Financial Fact:
Net revenues: 220.25M
Today's EPS Names:
UXIN, TOWN, NRIM, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q2 EPS of $0.48, $0.07 better than the analyst estimate of $0.41. Revenue for the quarter came in at $225 million versus the consensus estimate of $219.26 million.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Mobileye (MBLY) misses estimates for Q1 earnings, revenue; shares slip
- Applied Industrial Technologies (AIT) Tops Q3 EPS by 8c; Updates outlook
- Carrier Global (CARR) Tops Q1 EPS by 12c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
